💛 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
37853
CAS Number:
154598-52-4
Efavirenz
Grade:
meets USP specification
Purity:
98 - 102% (Solvent free basis)
Synonym(s):
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
Temperature Sensitive
Documents
$35.00 /5G
Pack Size Availability Price
Request Bulk Quote
Product Information

Efavirenz is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) widely utilized in the treatment of HIV-1 infection. This compound is recognized for its ability to effectively suppress viral replication, making it a crucial component of antiretroviral therapy regimens. Its unique structure, featuring a trifluoromethyl group and a cyclopropylethynyl moiety, contributes to its high selectivity and efficacy against the HIV virus. Efavirenz is often prescribed in combination with other antiretroviral agents to enhance therapeutic outcomes and improve patient adherence due to its once-daily dosing regimen.

In addition to its primary use in HIV treatment, Efavirenz has been the subject of extensive research for its potential applications in other viral infections and its role in pre-exposure prophylaxis (PrEP). The compound's favorable pharmacokinetic profile, including good oral bioavailability and a long half-life, allows for sustained antiviral activity, making it a valuable asset in both clinical and research settings. Researchers and healthcare professionals appreciate Efavirenz for its proven track record in improving patient outcomes and its ongoing relevance in the fight against HIV.

Synonyms
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
CAS Number
154598-52-4
Purity
98 - 102% (Solvent free basis)
Grade
meets USP specification
Molecular Formula
C14H9ClF3NO2
Molecular Weight
315.68
MDL Number
MFCD05662344
PubChem ID
3203
Appearance
White to slightly pink crystalline powder
Conditions
Store at ≤ 30 °
General Information
Synonyms
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
CAS Number
154598-52-4
Purity
98 - 102% (Solvent free basis)
Grade
meets USP specification
Molecular Formula
C14H9ClF3NO2
Molecular Weight
315.68
MDL Number
MFCD05662344
PubChem ID
3203
Appearance
White to slightly pink crystalline powder
Conditions
Store at ≤ 30 °
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Efavirenz is widely utilized in research focused on:

  • Antiretroviral Therapy: Primarily used in the treatment of HIV, Efavirenz is a key component of combination therapies, helping to suppress viral load and improve patient outcomes.
  • Pharmaceutical Development: Researchers leverage Efavirenz in the development of new antiviral drugs, studying its mechanisms and potential enhancements to improve efficacy and reduce side effects.
  • Clinical Trials: Efavirenz is frequently involved in clinical trials aimed at evaluating its effectiveness in various populations, including those with drug-resistant HIV strains.
  • Drug Interaction Studies: The chemical is used to assess interactions with other medications, providing valuable insights for healthcare providers in managing complex treatment regimens.
  • Pharmacokinetics Research: Researchers study the absorption, distribution, metabolism, and excretion of Efavirenz to optimize dosing strategies and improve therapeutic outcomes for patients.

Citations